Floatz logo

Iodixanol

Peripheral Arterial Disease

Nemocnice AGEL Trinec-Podlesi a.s.Small moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Peripheral Arterial Disease cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Shanghai CureGene Pharmaceutical Co., Ltd.
Phase 4BBB
Ranolazine
Colorado Prevention Center
Phase 4BB
Ezetimibe
University of Oxford
Phase 3B
SIMVASTATIN
University of Oxford
Phase 3B
ADVICOR COMPONENT NIACIN
University of Oxford
Phase 3B

View all 10 →

Same molecule, other indications

Iodixanol is also rated in:

carotid stenosisDormant
B
Indicative ·
63 / 100
View asset →
atherosclerosisDormant
B
Indicative ·
62 / 100
View asset →
Colon CancerDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →